Evidence-Based GI: An ACG Publication and Podcast

138 Episodes

1. ACG Guideline on Treatment of Helicobacter pylori: New Recommendations… Will Practice Change?

   Published: 9/18/2024
2. Vonoprazan is Efficacious for Non-Erosive Reflux Disease (NERD): An Alternative for PPI-Resistant NERD Patients?

   Published: 8/21/2024
3. ICYMI: ACG Clinical Guideline on Gastroparesis-Limited Evidence-Based Options

   Published: 8/21/2024
4. Risankizumab is Superior to Ustekinumab for Induction and Maintenance of Crohn’s disease: The SEQUENCE Trial

   Published: 8/21/2024
5. ERCP with Extracorporeal Shock-Wave Lithotripsy for Chronic Pancreatitis: Is It A “Sham” for Improving Pain?

   Published: 8/21/2024
6. Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study

   Published: 7/17/2024
7. Oral Vonoprazan for Prevention of High-Risk Peptic Ulcer Rebleeding: A Better Alternative than IV PPIs?

   Published: 7/17/2024
8. Do Not Extend Interval Between CRC Screening Colonoscopies from 10 to 15 Years: Perils of Administrative Databases

   Published: 7/17/2024
9. Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial

   Published: 7/17/2024
10. Multi-Target Stool RNA Test for Colorectal Cancer Screening: When Should You Use It?

    Published: 6/19/2024
11. Can IV Metoclopramide Improve Endoscopic Visualization for Patients with Active Upper Gastrointestinal Bleeding?

    Published: 6/19/2024
12. When to Discontinue Colon Polyp Surveillance in Older Adults?

    Published: 6/19/2024
13. Stemming the Tide: Is Long-acting, IM Octreotide Injection Better than Standard of Care for Angiodysplasia-related GI Bleeding?

    Published: 6/19/2024
14. PROFILE: Can Molecular Biomarkers Predict Outcomes to Crohn’s Disease Treatment?

    Published: 5/15/2024
15. Budesonide Oral Suspension Improves Outcomes in Eosinophilic Esophagitis

    Published: 5/15/2024
16. Multi-Target Stool DNA Test for CRC Screening: How Accurate is the New Version?

    Published: 5/15/2024
17. Linaclotide Effective for Functional Constipation in 6-17 Year Olds: First FDA-Approved Constipation Treatment for Children

    Published: 5/15/2024
18. How Effective Are Obesity Medications for Reducing Hepatic Decompensation in NASH?

    Published: 4/24/2024
19. Ustekinumab and Vedolizumab Demonstrate Safety During Pregnancy: Updates from the PIANO Registry

    Published: 4/24/2024
20. Resmetirom Produces NASH Resolution and Decreases Fibrosis: Results from the MAESTRO-NASH Trial

    Published: 4/24/2024